NASDAQ:CTMX
CytomX Therapeutics Stock News
$1.60
-0.0300 (-1.84%)
At Close: Apr 25, 2024
CytomX Therapeutics (CTMX) Reports Q2 Loss, Tops Revenue Estimates
06:57pm, Tuesday, 08'th Aug 2023
CytomX Therapeutics (CTMX) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.37 per share a year ago.
CytomX Therapeutics to Report Second Quarter 2023 Financial Results on August 8, 2023
08:00am, Tuesday, 01'st Aug 2023
SOUTH SAN FRANCISCO, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that it
CytomX Therapeutics to Present at the Jefferies Healthcare Conference
04:05pm, Thursday, 01'st Jun 2023
SOUTH SAN FRANCISCO, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sea
CytomX Therapeutics, Inc. (CTMX) Q1 2023 Earnings Call Transcript
11:13pm, Tuesday, 09'th May 2023
CytomX Therapeutics, Inc. (NASDAQ:CTMX ) Q1 2023 Results Conference Call May 9, 2023 5:00 PM ET Company Participants Chris Ogden - SVP, Finance & Accounting Sean McCarthy - CEO, Chairman Conference Ca
CytomX Therapeutics (CTMX) Reports Q1 Loss, Tops Revenue Estimates
07:07pm, Tuesday, 09'th May 2023
CytomX Therapeutics (CTMX) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.37 per share a year ago.
CytomX Therapeutics to Report First Quarter 2023 Financial Results on May 9, 2023
04:01pm, Monday, 01'st May 2023
SOUTH SAN FRANCISCO, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that it w
CytomX Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
04:05pm, Tuesday, 25'th Apr 2023
SOUTH SAN FRANCISCO, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Se
CytomX Therapeutics, Inc. (CTMX) Q4 2022 Earnings Call Transcript
07:51pm, Monday, 27'th Mar 2023
CytomX Therapeutics, Inc. (NASDAQ:CTMX ) Q4 2022 Earnings Conference Call March 27, 2023 5:00 PM ET Company Participants Chris Ogden - SVP of Finance and Accounting Sean McCarthy - CEO and Chairman Co
CytomX Therapeutics (CTMX) Reports Q4 Loss, Lags Revenue Estimates
07:02pm, Monday, 27'th Mar 2023
CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -100% and 94.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
CytomX Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 27, 2023
07:23pm, Wednesday, 22'nd Mar 2023
SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that it
CytomX Therapeutics to Present at Upcoming March Investor Conferences
04:05pm, Tuesday, 28'th Feb 2023
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sea
CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Investor Conference
04:05pm, Tuesday, 17'th Jan 2023
SOUTH SAN FRANCISCO, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sea
How to Start Investing in Penny Stocks in 2023
11:00am, Sunday, 08'th Jan 2023
Are you using these tips for investing in penny stocks? The post How to Start Investing in Penny Stocks in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
CytomX (CTMX) Up 55% on Strategic Partnership With Moderna
03:03pm, Friday, 06'th Jan 2023
CytomX (CTMX) inks an agreement with Moderna to develop therapeutics for oncology and non-oncology conditions. The company also provides its business outlook for 2023.
CytomX Therapeutics (CTMX) Stock Jumps 50% on Moderna Deal
02:45pm, Friday, 06'th Jan 2023
On a resoundingly positive Friday for the market, CytomX Therapeutics (NASDAQ: CTMX ) is providing a large portion of the fireworks. Specifically, CTMX stock skyrocketed more than 50% before settling
